Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malte Johannes Hannich

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cells|April 3, 2021
Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease PatternMalte Johannes Hannich, Alexander Dressel, Kathrin Budde, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 19, 2020
Free light chains kappa can differentiate between myelitis and noninflammatory myelopathyMarie Süße, Fritz Feistner, Matthias Grothe, et al.
Acta Neurologica Scandinavica|April 3, 2019
Intrathecal inflammation in young strokeMarie Süße, Malte Johannes Hannich, Christine Holbe, et al.
Journal of Neuroimmunology|June 30, 2020
Free light chain kappa and the polyspecific immune response in MS and CIS - Application of the hyperbolic reference range for most reliable data interpretationMarie Süße, Hansotto Reiber, Matthias Grothe, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 2020
Diagnostic value of kappa free light chains in patients with one isolated band in isoelectric focusingMarie Süße, Fritz Feistner, Christine Holbe, et al.
Biomolecules|November 24, 2022
A New Laboratory Workflow Integrating the Free Light Chains Kappa Quotient into Routine CSF AnalysisMalte Johannes Hannich, Mohammed R Abdullah, Kathrin Budde, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying TreatmentMarie Süße, Franz Felix Konen, Philipp Schwenkenbecher, et al.
Brain Sciences|April 21, 2022
Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological DiseasesFranz Felix Konen, Philipp Schwenkenbecher, Konstantin Fritz Jendretzky, et al.
Biomedicines|July 27, 2022
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple SclerosisFranz Felix Konen, Malte Johannes Hannich, Philipp Schwenkenbecher, et al.
Frontiers in Immunology|April 3, 2026
Kappa free light chains in cerebrospinal fluid to detect inflammation - results from a multicentric prospective real-world studyMarie Süße, Malte Johannes Hannich, Felix Lottermoser, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cells|April 3, 2021
Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease PatternMalte Johannes Hannich, Alexander Dressel, Kathrin Budde, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 19, 2020
Free light chains kappa can differentiate between myelitis and noninflammatory myelopathyMarie Süße, Fritz Feistner, Matthias Grothe, et al.
Acta Neurologica Scandinavica|April 3, 2019
Intrathecal inflammation in young strokeMarie Süße, Malte Johannes Hannich, Christine Holbe, et al.
Journal of Neuroimmunology|June 30, 2020
Free light chain kappa and the polyspecific immune response in MS and CIS - Application of the hyperbolic reference range for most reliable data interpretationMarie Süße, Hansotto Reiber, Matthias Grothe, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 2020
Diagnostic value of kappa free light chains in patients with one isolated band in isoelectric focusingMarie Süße, Fritz Feistner, Christine Holbe, et al.
Biomolecules|November 24, 2022
A New Laboratory Workflow Integrating the Free Light Chains Kappa Quotient into Routine CSF AnalysisMalte Johannes Hannich, Mohammed R Abdullah, Kathrin Budde, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying TreatmentMarie Süße, Franz Felix Konen, Philipp Schwenkenbecher, et al.
Brain Sciences|April 21, 2022
Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological DiseasesFranz Felix Konen, Philipp Schwenkenbecher, Konstantin Fritz Jendretzky, et al.
Biomedicines|July 27, 2022
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple SclerosisFranz Felix Konen, Malte Johannes Hannich, Philipp Schwenkenbecher, et al.
Frontiers in Immunology|April 3, 2026
Kappa free light chains in cerebrospinal fluid to detect inflammation - results from a multicentric prospective real-world studyMarie Süße, Malte Johannes Hannich, Felix Lottermoser, et al.
Pageof 1